ClinicalTrials.gg
CompletedNCT07907874Updated Oct 30, 2026

The Effect of Tecar Therapy in Patients With Chronic Neck Pain

An interventional study of Tecar therapy in Neck Pain, Signs and Symptoms and Disability Physical, sponsored by Ankara City Hospital Bilkent. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-30.

Sponsored by Ankara City Hospital Bilkent · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years 5 months after the study started (first participant enrolled May 2023, registered Oct 2026).
Updated Oct 30, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
59
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 296 studies in Neck Pain with a site in Turkey — 70 open to participants now, 78 under way, none of them phase 3. Neck Pain · Turkey.

Enrollment
76th of 216
59 · median 45
Started
2023
with 32 others
No phase
215 of 296
47 open now
Registered
295th of 296
by date

Among the 296 studies in Neck Pain with a site in Turkey, this one is the 76th largest by enrollment of the 216 interventional ones, is one of 33 that started in 2023, is one of 215 with no phase, and was the 295th registered.

By phase

296 studies; the count open now beside each. This study's row is marked.

No phasethis study215 · 47 open
Observational80 · 23 open
Phase 21 · 0 open

By the year they started

First in 2011; this study’s year is marked. 33 started in 2023.

What they test

Size and results

Median enrollment 45 across the 216 interventional studies, 80 across the 80 observational. Of the 201 that completed or were terminated, 1 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 296 studies in Neck Pain with a site in Turkey, or all of them as a file.
02

Study summary

Neck pain is a highly prevalent musculoskeletal disorder. Alongside pharmacological treatments, evidence supports the efficacy of physical therapy modalities and exercise in managing chronic neck pain. Ultrasound (US) is a well-established physical therapy modality that delivers ultrasonic sound waves to target tissues. More recently, TECAR (Transfer of Energy Capacitive and Resistive) therapy has gained traction as an innovative clinical application; it operates as an endogenous thermotherapy designed to heat both superficial and deep tissues. The aim of this study is to evaluate and compare the effects of conventional physical therapy and the increasingly adopted TECAR therapy on pain, disability, quality of life, and kinesiophobia in patients with chronic neck pain.

Read the detailed description

Group 1: TENS, Ultrasound, and exercise will be applied. Group 2: TENS, TECAR Therapy, and exercise therapy will be applied for 10 sessions (5 days a week for 2 weeks).

The exercise program consists of range of motion exercises, strengthening exercises, balance-coordination, and posture exercises. Patients will be evaluated before treatment, and at the 1st and 3rd months post-treatment. Demographic characteristics, medical history, symptoms, and symptom characteristics will be queried; detailed neurological and musculoskeletal examinations and range of motion measurements will be performed.

The demographic characteristics, medical histories, and symptom profiles of the patients will be recorded. Subsequently, comprehensive neurological and musculoskeletal examinations, along with range of motion (ROM) measurements, will be performed. Hand grip strength will be measured using a hand dynamometer. Clinical assessments will include the evaluation of pain intensity using the Visual Analog Scale (VAS), cervical posture via the C7-to-wall distance, neck disability through the Neck Disability Index, quality of life using the Nottingham Extended Activities of Daily Living scale, and kinesiophobia with the Tampa Scale for Kinesiophobia .

03

Conditions studied

  • Neck Pain
  • Signs and Symptoms
  • Disability Physical

Keywords

  • neck pain
  • TECAR
  • physical therapy
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Ages 18-65, neck pain persisting for 3 months or longer, restricted movement, complaints of difficulty in daily living activities, and possession of cognitive ability.

Exclusion criteria

Exclusion Criteria:

  • Signs/symptoms of myelopathy, other neck/upper extremity diseases, history of neck trauma or cervical surgery, history of rheumatologic disease, neurological disease, diabetes, or cancer, presence of active infection, pregnancy, presence of a cardiac pacemaker, oral use, injection to the cervical region within the last 3 months, physical therapy applied to the neck within the last 6 months, presence of advanced degeneration on imaging.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
59 participants (actual)

Study arms

  • Experimental
    Tecar therapy

    Tecar therapy application will be applied to the muscle groups in the neck region at a fixed frequency of 0.448 Mhz for 10 minutes five days a week for a total of 10 sessions

    Device: Tecar therapy

  • Active comparator
    Ultrasound

    Patients in the conventional physical therapy group received therapeutic ultrasound (US) applied to the cervical region. The US was administered at an intensity of 1.5 W/cm² in continuous mode. The treatment protocol was performed five days a week for a total of 10 sessions

    Device: Tecar therapy

Interventions

  • DeviceTecar therapy

    Patients in the conventional physical therapy group received therapeutic ultrasound (US) applied to the cervical region. The US was administered at an intensity of 1.5 W/cm² in continuous mode. The treatment protocol was performed five days a week for a total of 10 sessions. Tecar therapy application will be applied to the muscle groups in the neck region at a fixed frequency of 0.448 Mhz for 10 minutes five days a week for a total of 10 sessions.

    Also known as: Ultrasound

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS) Neck Disability İndex

    scale used for pain assessment consisting of a 10 cm horizontal or vertical line. '0' represents no pain, and '10' represents the worst pain experienced.

    Time frame: 0-12 weeks

  2. Cervical Range of Motion with goniometer

    Active cervical range of motion (ROM), including flexion, extension, lateral flexion, and rotation, was measured using a universal goniometer.

    Time frame: 0-12 weeks

Secondary outcomes

  1. Neck Disability Index

    The NDI includes a total of 10 questions such as pain, personal care, concentration, work, driving, and sleeping. Each question is scored between 0 and 5 points. A score of 0 means no restriction, and a score of 50 means full restriction.

    Time frame: 0-12 week

  2. Tampa Kinesiophobia Scale

    The scale uses a 4-point Likert scale (1= I strongly disagree, 4= I strongly agree). A total score is calculated after reversing items 4, 8, 12, and 16. The person receives a total score between 17-68.

    Time frame: 0-12 week

  3. Nottingham Extended Activities of Daily Living Scale

    Contains four sub-sections: mobility (6 items), kitchen (5 items), domestic tasks (5 items), and leisure activities (6 items). Scoring: 0 (Cannot do at all), 1 (Do with help), 2 (Do alone with difficulty), 3 (Do alone easily). Total score ranges from 0-66.

    Time frame: 0-12 week

07

Study locations

1 site
  • Ankara Billkent City Hospital
    Ankara, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2023 to primary completion in Dec 2023, 7 months.

Of 763 non-industry interventional studies with no phase under Neck Pain, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's 7 months is close to that.

Counting every sponsor, half of 772 studies reached it within 7 months; a quarter within 3 and three quarters within 15.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Oct 30, 2026
StartActual
May 10, 2023
Primary completionActual
Dec 10, 2023
CompletionActual
Jun 25, 2024
Last update
Oct 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 30, 2026
Show all 1 update
  1. Oct 30, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07907874
Responsible party
Refiye Önal (Medical Doctor, Ankara City Hospital Bilkent) — Principal investigator
First posted
Oct 30, 2026
Start date
May 10, 2023
Primary completion
Dec 10, 2023
Completion
Jun 25, 2024
Last update
Oct 30, 2026

Study contacts

Sevgi Atalay
study chair · Ankara City Hospital Bilkent

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion